Alas! Ileal Interposition Surgery for Diabetes Prevention?

Gastroenterology

Volumn 138, Issue 7, 2010, Pages 2224-2226

  Ahima, Rexford S ^a   Carr, Rotonya ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 AGONIST; INSULIN; UNCLASSIFIED DRUG;

BILIOPANCREATIC BYPASS; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; EDITORIAL; GASTRECTOMY; GASTRIC BANDING; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; ILEUM; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; INTESTINE SURGERY; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SURGICAL TECHNIQUE;

EID: 77952677026     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.04.025     Document Type: Editorial

References (19)

1. James W.P. The epidemiology of obesity: the size of the problem. J Intern Med 263 (2008) 336-352
2. Centers for Disease Control and Prevention 2008 Diabetes Public Health Resource. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf Accessed March 19, 2010
3. World Health Organization. http://www.who.int/diabetes/facts/world_figures/en/ Accessed March 20, 2010
4. Crandall J.P., Knowler W.C., Kahn S.E., et al. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab 4 (2008) 382-393
5. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
6. Delahanty L.M., and Nathan D.M. Implications of the diabetes prevention program and Look AHEAD clinical trials for lifestyle interventions. J Am Diet Assoc 108 4 suppl 1 (2008) S66-S72
7. Rubino F., Schauer P.R., Kaplan L.M., et al. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 61 (2010) 393-411
8. Cummings B.P., Strader A.D., Stanhope K.L., et al. Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology 138 (2010) 2437-2446
9. Cummings B.P., Digitale E.K., Stanhope K.L., et al. Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat. Am J Physiol Regul Integr Comp Physiol 295 (2008) R1782-R1793
10. Strader A.D. Ileal transposition provides insight into the effectiveness of gastric bypass surgery. Physiol Behav 88 (2006) 277-282
11. Strader A.D., Vahl T.P., Jandacek R.J., et al. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab 288 (2005) E447-E453
12. Mason E. Ileal transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 9 (1999) 223-228
13. Baggio L.L., and Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 132 (2007) 2131-2157
14. Kindel T.L., Yoder S.M., Seeley R.J., et al. Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. J Gastrointest Surg 13 (2009) 1762-1772
15. Wren A.M., and Bloom S.R. Gut hormones and appetite control. Gastroenterology 132 (2007) 2116-2130
16. Fiorucci S., Mencarelli A., Palladino G., et al. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol Sci 30 (2009) 570-580
17. Kumar H., Ugale S., Gupta N., et al. Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabet Technol Ther 11 (2009) 785-789
18. De Paula A.L., Stival A.R., Macedo A., et al. Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m(2). Surg Obes Relat Dis 36 (2009) Nov 10 [Epub ahead of print]
19. Rehfeld J.F. A centenary of gastrointestinal endocrinology. Horm Metab Res 36 (2004) 735-741